Moderna (MRNA) Is Up 14.8% After Filing Global Applications For Its mRNA Flu Vaccine mRNA-1010 [Yahoo! Finance]
Ares Capital Corporation - Closed End Fund (ARCC)
Last ares capital corporation - closed end fund earnings: 2/12 06:22 am
Check Earnings Report
US:NASDAQ Investor Relations:
arescapitalcorp-ir.com
Company Research
Source: Yahoo! Finance
Australia for adults aged 50 and older, supported by positive Phase 3 data showing relative vaccine efficacy of about 27% and a favorable safety profile. This move marks a key test of Moderna's effort to extend its mRNA platform beyond COVID-19, potentially broadening its respiratory vaccine portfolio and reducing reliance on a single product category. We'll now examine how the regulatory filings for mRNA-1010, backed by Phase 3 data, could influence Moderna's broader investment narrative. Rare earth metals are the new gold rush. Find out which 39 stocks are leading the charge To own Moderna, you need to believe its mRNA platform can support a broader, commercially successful portfolio beyond COVID-19, while the company manages current losses and revenue volatility. The mRNA-1010 filings are directionally helpful for diversification, but they do not remove the near term risk that seasonal respiratory vaccines, on their own, may not stabilize revenues or earnings. Among recen
Show less
Read more
Impact Snapshot
Event Time:
ARCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARCC alerts
High impacting Ares Capital Corporation - Closed End Fund news events
Weekly update
A roundup of the hottest topics
ARCC
News
- 3 Brilliant Dividend Stocks to Buy Now and Hold for the Long Term [Yahoo! Finance]Yahoo! Finance
- Ares Capital Corporation (ARCC): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Better Dividend Stock: AGNC Investment vs. Ares Capital [Yahoo! Finance]Yahoo! Finance
- 3 Top Dividend Stocks to Buy in January [Yahoo! Finance]Yahoo! Finance
- The Best Dividend Stocks to Buy With $2,000 Right Now [Yahoo! Finance]Yahoo! Finance
ARCC
Earnings
- 10/28/25 - In-Line
ARCC
Sec Filings
- 1/12/26 - Form 8-K
- 1/7/26 - Form 424B2
- 1/5/26 - Form 497AD
- ARCC's page on the SEC website